NPs Basic Information

Name
Galiellalactone
Molecular Formula C11H14O3
IUPAC Name*
(4R,7R,9S,11S)-11-hydroxy-9-methyl-3-oxatricyclo[5.3.1.04,11]undec-1(10)-en-2-one
SMILES
C[C@H]1C[C@H]2CC[C@@H]3[C@]2(C(=C1)C(=O)O3)O
InChI
InChI=1S/C11H14O3/c1-6-4-7-2-3-9-11(7,13)8(5-6)10(12)14-9/h5-7,9,13H,2-4H2,1H3/t6-,7+,9+,11-/m0/s1
InChIKey
SOIISBQQYAGDKM-QJSROADHSA-N
Synonyms
Galiellalactone; 133613-71-5; (-)-Galiellalactone; CHEMBL3823609; SCHEMBL17081865; NSC771565; ZINC96032826; AKOS006309836; NSC-771565; HY-125170; CS-0089754; (4S,5aR,7aR,7bS)-5,5a,6,7,7a,7b-Hexahydro-7b-hydroxy-4-methylindeno[1,7-bc]furan-2(4H)-one
CAS NA
PubChem CID 11310070
ChEMBL ID CHEMBL3823609
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Lactones
        • Subclass: Gamma butyrolactones
          • Direct Parent: Gamma butyrolactones

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 194.23 ALogp: 0.9
HBD: 1 HBA: 3
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 46.5 Aromatic Rings: 3
Heavy Atoms: 14 QED Weighted: 0.594

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.54 MDCK Permeability: 0.00004730
Pgp-inhibitor: 0 Pgp-substrate: 0.14
Human Intestinal Absorption (HIA): 0.01 20% Bioavailability (F20%): 0.006
30% Bioavailability (F30%): 0.149

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.963 Plasma Protein Binding (PPB): 59.80%
Volume Distribution (VD): 1.291 Fu: 45.44%

ADMET: Metabolism

CYP1A2-inhibitor: 0.348 CYP1A2-substrate: 0.12
CYP2C19-inhibitor: 0.087 CYP2C19-substrate: 0.666
CYP2C9-inhibitor: 0.018 CYP2C9-substrate: 0.097
CYP2D6-inhibitor: 0.005 CYP2D6-substrate: 0.424
CYP3A4-inhibitor: 0.029 CYP3A4-substrate: 0.156

ADMET: Excretion

Clearance (CL): 6.229 Half-life (T1/2): 0.19

ADMET: Toxicity

hERG Blockers: 0.034 Human Hepatotoxicity (H-HT): 0.965
Drug-inuced Liver Injury (DILI): 0.345 AMES Toxicity: 0.534
Rat Oral Acute Toxicity: 0.755 Maximum Recommended Daily Dose: 0.568
Skin Sensitization: 0.262 Carcinogencity: 0.067
Eye Corrosion: 0.074 Eye Irritation: 0.211
Respiratory Toxicity: 0.936
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003700 0.444 D0A2AJ 0.236
ENC005798 0.444 D0G6AB 0.232
ENC003701 0.439 D0K7LU 0.222
ENC003480 0.345 D06AEO 0.222
ENC005043 0.305 D0U3GL 0.220
ENC002040 0.293 D0I2SD 0.216
ENC002355 0.282 D04GJN 0.216
ENC004785 0.282 D04CSZ 0.214
ENC004784 0.274 D04JHN 0.207
ENC003670 0.268 D0Q6NZ 0.207
*Note: the compound similarity was calculated by RDKIT.